Inndura Therapeutics (Uk) Limited
14240690
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 17/07/2025
Due 31/07/2026
Industry
Officers
Persons with Significant Control
Kin Fei Adrian Chan
Singaporean · Hong Kong · Age 52
Unit 1605 Tower 2 China Central Place, 79 Jianguo Road, Beijing, 100025
Notified 30/08/2024
Former PSCs
John Beadle
Ceased 30/08/2024
CompanyRankvs 1522+ SIC 72110 peers52
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£1
Balance sheet strength
Cash
£13k
Cash in the bank
Net Current Assets
£28k
Working capital
Current Assets
£33k
Current Liabilities
£6k
Debtors
£21k
Tax at Year End
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 5.82 |
Derived from filed accounts. Not audited figures.